Hospital
Franciscan Health Dyer & Hammond
Franciscan Health Dyer & Hammond was paid $3.28M by Medicaid between Jan 2018 and Dec 2022, across 59 billing codes. Its largest line is 99283, emergency room visit (moderate) — 33% of everything it billed.
33Billing provider infoFRANCISCAN HEALTH DYER & HAMMOND
HAMMOND, IN 46320
HAMMOND, IN 46320
33aNPI1306921911assigned 10/25/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.28M
24GClaims42,431
24DCodes billed59
24AFirst – last monthJan 2018 – Dec 2022
Compared with peers
Next to other General Acute Care Hospital providers in Indiana
Rank by total paid#47 of 69
Median peer was paid$9.76M
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,849 | $559K | |
| 2019 | 7,934 | $697K | |
| 2020 | 5,000 | $577K | |
| 2021 | 8,345 | $765K | |
| 2022 | 8,303 | $685K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 33% | 8,650 | 7,655 | $1.09M |
| 41899 | Unlisted procedure, dentoalveolar structures | 24% | 550 | 497 | $799K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 4,207 | 3,475 | $450K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 8.5% | 1,829 | 1,602 | $280K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 8.0% | 1,636 | 655 | $261K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.9% | 1,194 | 936 | $62K |
| 71045 | Radiologic examination, chest; single view | 1.6% | 488 | 369 | $53K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.5% | 783 | 696 | $50K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.1% | 433 | 354 | $37K |
| 80053 | Comprehensive metabolic panel | <1% | 4,600 | 3,700 | $27K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 439 | 386 | $27K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 352 | 320 | $23K |
47 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,768 | $22K |
| 96367 | <1% | 313 | $12K | |
| 96523 | <1% | 184 | $11K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 378 | $9K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 378 | $9K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,413 | $8K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 221 | $5K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 96 | $4K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 198 | $4K |
| 86769 | <1% | 121 | $3K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 61 | $3K |
| 86003 | <1% | 21 | $3K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 29 | $2K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 136 | $2K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 110 | $2K |
| 81025 | <1% | 352 | $2K | |
| 80061 | Lipid panel | <1% | 251 | $2K |
| 81001 | <1% | 759 | $2K | |
| 84484 | <1% | 258 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 285 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 232 | $1K |
| 86780 | <1% | 124 | $1K | |
| 87660 | <1% | 86 | $1K | |
| 87510 | <1% | 86 | $1K | |
| 87480 | <1% | 86 | $1K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 90 | $998.01 |
| 87481 | <1% | 26 | $714.51 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 134 | $705.19 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 42 | $670.88 |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 20 | $564.59 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 20 | $504.36 |
| 83655 | <1% | 38 | $487.09 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 19 | $408.24 |
| 85027 | <1% | 141 | $398.28 | |
| 83735 | <1% | 91 | $360.28 | |
| 82785 | <1% | 19 | $279.82 | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 20 | $263.00 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 22 | $161.66 |
| 87081 | <1% | 13 | $84.33 | |
| 87430 | <1% | 13 | $68.76 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 1,497 | $66.18 |
| 83690 | <1% | 14 | $59.45 | |
| 82950 | <1% | 15 | $16.93 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 324 | $9.52 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 133 | $1.10 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 357 | $0.59 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 276 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGOLAN, JOSEPH (CFO-NORTHWEST INDIANA)
| Provider | Location | Paid |
|---|---|---|
| Franciscan Health Dyer & Hammond | Dyer, IN | $4.52M |
| Franciscan Health Munster | Munster, IN | $2.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.